| IPO Company Profile © ipodata.com |
| Message Board | Quote | Chart | News | SEC Filings | Peer IPO Companies | Company's Home Page |
| Bruker AXS Inc. |
| 5465 East Cheryl Parkway, Madison, WI 53711 * (608) 276-3000 |
| Business Description | The company is a leading worldwide developer and provider of advanced integrated X-ray systems which provide solutions for molecular and elemental analysis by X-ray diffraction and X-ray fluorescence. |
| Offering Information Company has | |||
| Trading As | BAXS (NASNTL) | Industry | Manufacturing (SIC 3826) |
| Type of Stock Offered | Common Shares | Filing Date | 7/27/2001 |
| Domestic Shares Offered | 9,000,000 | Offer Date | 12/14/2001 |
| Foreign Shares Offered | 0 | Filing Range | $8.00 - $10.00 |
| Company Shares | 9,000,000 | Offer Price | $6.50 |
| Selling Shrhldrs Shares | 0 | Gross Spread | $0.460 |
| Gross Proceeds | $58,500,000 | Selling | $0.275 |
| Expenses | - - | Reallowance | $0.100 |
| Post-IPO Shares | - - | Employees | 460 |
| Primary Underwriting Group | ||
| Underwriter Name | Participation | Underwriter Phone |
| UBS Warburg LLC | Lead Manager | |
| CIBC World Markets | Co-manager | (212) 667-7400 |
| Robert W. Baird & Company | Co-manager | (414) 765-3632 |
| SG Cowen | Co-manager | (212) 495-6000 |
| Thomas Weisel Partners LLC | Co-manager | (415) 364-2500 |
| Income Statement and Cash Flow Summary | |||||||
| Prior Audited Income |
Latest Unaudited Income | ||||||
| Full Year Audited Figures | 3 Months Ending | ||||||
| Figures in U.S. millions except per share data | 9/30/1998 | 9/30/1999 | 12/31/2000 | 3/31/2000 | 3/31/2001 | ||
| Revenues | - | - | 57.261 | 61.894 | 68.105 | 18.112 | 18.845 |
| Income from Oper. | - | - | -0.199 | -0.078 | 2.103 | 1.099 | 0.778 |
| Net Income | - | - | -0.718 | 0.024 | 0.729 | 0.296 | 0.264 |
| E.P.S | - | - | - | - | - | - | - |
| Revenue Growth (%) | - | - | 8.09 | 10.035 | 4.05 | ||
| Net Income Growth (%) | - | - | - | 2,937.50 | -10.81 | ||
| Oper. Profit Margin (%) | - | - | - | - | 3.09 | 4.13 | 6.07 |
| Net Profit Margin (%) | - | - | - | 0.04 | 1.07 | 1.40 | 1.63 |
| Cash Flow - Oper. | 0.73 | - | - | ||||
| Cash Flow - Inv. | 0.40 | - | - | ||||
| Cash Flow - Fin. | -2.00 | - | - | ||||
| Balance Sheet Summary and Financial Ratios | |||||
| Balance sheet as of: 3/31/2001 | Financial Ratios | ||||
| Total Assets | 62.03 | Current Assets | - | Current Ratio | - |
| Total Liab. | 59.32 | Current Liab. | - | Debt Ratio | 95.63% |
| Total Equity | 2.71 | Working Cap. | 30.52 | Debt to Equity Ratio | 21.86 |
| Cash | 19.53 | Return on Assets | 0.43% | ||
| Use Of Proceeds |
The proceeds from the proposed offering will be used for general corporate purposes including research and development, expansion of global marketing and distribution capabilities, working capital, funding potential strategic acquisitions and joint ventures and repayment ofoutstanding debt. |
| Legal Counsel Registrar Auditor | |
| Issuer's Law Firm | Hutchins Wheeler & Dittmar |
| Bank's Law Firm | Dewey Ballantine |
| Auditor | Pricewaterhouse Coopers LLC |
| Send us feedback if you would like to request that we hyperlink a firm on this page | |